Vaccination 

The development of polio vaccines by Jonas Salk was the biggest breakthrough in medicinal history of the 20th century. The first production of polio vaccines plan was to transport polio vaccines to amplify the virus at local production facilities. There are currently four types of polio vaccines known to men at the moment; inactivated polio vaccine (the IPV), which contains no live polio virus, oral polio vaccine (OPV) that contains live, weakened polio virus, bivalent oral polio vaccine (bOPV) which is most affective than OPV against type 1 and 3, and the other is monovalent oral polio vaccine (mOPV)  which has been proven to be the most safest of all vaccines. 
Of these four vaccines, the IPV and OPV vaccinations are the general types used to help ward off polio. After 2 doses of enhanced-potency IPV, high levels of serum-neutralizing antibodies to all 3 types of poliovirus appears in 94-100% of individuals, and after 3 doses, seroconversion appears in 99-100% of individuals. In infants, they receive 3 injections per dose. The 1st administration being at the age of 6-8 weeks and the 2nd administration at the age of 4-6 months. As in adults (unvaccinated ones), they receive 2 injections per dose. The 1st administration is at a 1-2 month interval of 2 injections and the 2nd injection 6-12 months after. The side effect of these injections towards your nervous system includes Guillian-Barre Barre Syndrome, associated only with the Inactivated Polio Vaccine.
Picture
Jonas Salk's vaccine published on front page newspaper